Evidence map›Paper›PMID 33182300›Full record

ArticleCells2020

Calcitriol Suppresses HIF-1 and HIF-2 Transcriptional Activity by Reducing HIF-1/2α Protein Levels via a VDR-Independent Mechanism.

Ioanna-Maria Gkotinakou, Eleni Kechagia, Kalliopi Pazaitou-Panayiotou, Ilias Mylonis, Panagiotis Liakos, Andreas Tsakalof

Open access · goldAbstract read
In one paragraph

Article in Cells, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. HIF-1 and HIF-2 in cancer: structure, regulation, and therapeutic prospects.Cellular and molecular life sciences : CMLS · 2025
    Review
  10. Review
  11. Review
  12. 1α,25-Dihydroxyvitamin DCurrent issues in molecular biology · 2023
    Article
  13. Article
  14. Review
  15. Review
  16. Vitamin DFrontiers in cellular and infection microbiology · 2022
    Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ioanna-Maria GkotinakouLaboratory of Biochemistry, Faculty of Medicine, University of Thessaly, Biopolis 41500, Larissa, Greece.ORCID 0000-0003-0529-053X
Eleni KechagiaLaboratory of Biochemistry, Faculty of Medicine, University of Thessaly, Biopolis 41500, Larissa, Greece.
Kalliopi Pazaitou-PanayiotouDivision of Endocrinology, Interbalkan Medical Center, Thessaloniki 55535, Greece.
Ilias MylonisLaboratory of Biochemistry, Faculty of Medicine, University of Thessaly, Biopolis 41500, Larissa, Greece.ORCID 0000-0002-0893-6618
Panagiotis LiakosLaboratory of Biochemistry, Faculty of Medicine, University of Thessaly, Biopolis 41500, Larissa, Greece.
Andreas TsakalofLaboratory of Biochemistry, Faculty of Medicine, University of Thessaly, Biopolis 41500, Larissa, Greece.ORCID 0000-0003-4702-0394
University of Thessaly · GRInterbalkan Medical Center · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypoxia-inducible transcription factors 1 and 2 (HIFs) are major mediators of cancer development and progression and validated targets for cancer therapy. Although calcitriol, the biologically active metabolite of vitamin D, was attributed with anticancer properties, there is little information on the effect of calcitriol on HIFs and the mechanism underling this activity. Here, we demonstrate the negative effect of calcitriol on HIF-1/2α protein levels and HIF-1/2 transcriptional activity and elucidate the molecular mechanism of calcitriol action. We also reveal that the suppression of vitamin D receptor (VDR) expression by siRNA does not abrogate the negative regulation of HIF-1α and HIF-2α protein levels and HIF-1/2 transcriptional activity by calcitriol, thus testifying that the mechanism of these actions is VDR independent. At the same time, calcitriol significantly reduces the phosphorylation of Akt protein kinase and its downstream targets and suppresses HIF-1/2α protein synthesis by inhibiting

Indexed as

Transcription, GeneticBasic Helix-Loop-Helix ProteinsCalcitriolCell Line, TumorDown-RegulationEndothelial PAS Domain-Containing Protein 1HumansHypoxia-Inducible Factor 1Models, BiologicalPhosphatidylinositol 3-KinasesProtein BiosynthesisProto-Oncogene Proteins c-aktReceptors, CalcitriolRNA, MessengerRNA, Small InterferingSignal TransductionBasic Helix-Loop-Helix ProteinsCalcitriolEndothelial PAS Domain-Containing Protein 1Hypoxia-Inducible Factor 1Phosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktReceptors, CalcitriolRNA, MessengerRNA, Small InterferingTOR Serine-Threonine Kinasescalcitriolcancerhypoxiahypoxia-inducible factorsVDRvitamin D

Identifiers

PMID33182300
PMCPMC7695316
OpenAlexW3100853318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.